Sera Prognostics Stock In The News

SERA Stock  USD 6.38  0.16  2.45%   
Our overall analysis of Sera Prognostics' news coverage and content from conventional and social sources shows investors' bearish mood towards Sera Prognostics. The specific impact of Sera Prognostics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Sera Prognostics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Sera Prognostics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Sera Prognostics Backtesting and Sera Prognostics Hype Analysis.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

Sera Prognostics Today Top News and Investor Outlook

Yahoo News
3 Stocks Under $10 With the Potential to Make You a Millionaire
https://finance.yahoo.com/news/3-stocks-under-10-potential-101700519.html
 Bullish
Yahoo News
Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
https://finance.yahoo.com/news/sera-prognostics-inc-sera-may-140002739.html
 Bullish
Macroaxis News: globenewswire.com
Sera Prognostics Appoints Dr. Paul Kearney as Chief Data Officer
https://www.globenewswire.com/news-release/2021/09/28/2304455/0/en/Sera-Prognostics-Appoints-Dr-Paul-Kearney-as-Chief-Data-Officer.html
 Bullish
Macroaxis News: globenewswire.com
Sera Prognostics to be Added to Russell 2000 Index
https://www.globenewswire.com/news-release/2021/09/20/2299779/0/en/Sera-Prognostics-to-be-Added-to-Russell-2000-Index.html
 Bullish
Macroaxis News: globenewswire.com
Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer
https://www.globenewswire.com/news-release/2021/09/15/2297448/0/en/Sera-Prognostics-Appoints-Dr-Michael-R-Foley-as-Chief-Medical-Officer.html
 Bullish
Macroaxis News: globenewswire.com
Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
https://www.globenewswire.com/news-release/2021/09/13/2295685/0/en/Sera-Prognostics-to-Present-at-Oppenheimer-Fall-Healthcare-Life-Sciences-Med-Tech-Summit.html
 Neutral
Macroaxis News: globenewswire.com
Sera Prognostics Reports Second Quarter 2021 Financial Results
https://www.globenewswire.com/news-release/2021/08/30/2288680/0/en/Sera-Prognostics-Reports-Second-Quarter-2021-Financial-Results.html
 Neutral
Yahoo News
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
https://finance.yahoo.com/news/week-ahead-biotech-aug-8-140332684.html
 Neutral

Sera Prognostics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Sera and other traded companies coverage with news coverage. We help investors stay connected with Sera headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Sera Stock performance. Please note that trading solely based on the Sera Prognostics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Sera Prognostics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Sera Prognostics investors visualize upcoming and past events in order to time the market based on Sera Prognostics noise-free hype analysis.
Sera Prognostics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Sera earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Sera Prognostics that are available to investors today. That information is available publicly through Sera media outlets and privately through word of mouth or via Sera internal channels. However, regardless of the origin, that massive amount of Sera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sera Prognostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sera Prognostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sera Prognostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sera Prognostics alpha.

Sera Largest EPS Surprises

Earnings surprises can significantly impact Sera Prognostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-05-10
2023-03-31-0.38-0.340.0410 
2023-03-22
2022-12-31-0.37-0.310.0616 
2023-11-08
2023-09-30-0.34-0.230.1132 
2022-03-29
2021-12-31-0.29-0.41-0.1241 
2021-11-09
2021-09-30-0.25-0.39-0.1456 
2022-11-09
2022-09-30-0.56-0.350.2137 
View All Earnings Estimates

Sera Prognostics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Sera Prognostics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
18th of November 2024
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health a...
at news.google.com 
news
13th of November 2024
Sera Prognostics, Inc. CEO Zhenya Lindgardt Sells 12,075 Shares of Stock
at thelincolnianonline.com 
Investing News at Macroaxis
12th of November 2024
Sera Prognostics CEO Lindgardt Zhenya sells shares worth 88,389
at investing.com 
Yahoo News
8th of November 2024
Sera Prognostics Third Quarter 2024 Earnings Misses Expectations
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
6th of November 2024
Sera Prognostics Inc Reports Q3 2024 Revenue of 29,000, Missing Estimates of 90,000 ...
at gurufocus.com 
Yahoo News
28th of October 2024
Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 F...
at finance.yahoo.com 
prnewswire News
7th of October 2024
EICMA 2024 LDITION RECORD SERA INAUGURE DANS UN MOIS
at prnewswire.com 
Usa forbes News
1st of October 2024
Banijay, SERA Reveal Details Of Their Space Reality Show
at forbes.com 
Google News at Macroaxis
11th of September 2024
Sera prognostics CFO sells over 38k in company stock - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sera Prognostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sera Prognostics' short interest history, or implied volatility extrapolated from Sera Prognostics options trading.
When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:
Check out Sera Prognostics Backtesting and Sera Prognostics Hype Analysis.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
0.003
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.